Scholarly Index
James E. Bradner
Novartis (China); 53,771 total citations; 362 total publications; best world rank #19
Novartis (China)
53,771Total citations
362Total publications
114H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Protein Degradation and Inhibitors | Lifetime | 19 | CN 1 | 99.79 |
| Ubiquitin and proteasome pathways | Lifetime | 41 | CN 3 | 99.68 |
| Histone Deacetylase Inhibitors Research | Lifetime | 26 | CN 2 | 99.62 |
| Multiple Myeloma Research and Treatments | Lifetime | 138 | CN 1 | 99.06 |
| Chromatin Remodeling and Cancer | Lifetime | 429 | CN 9 | 90.59 |